DEUTSCHE BANK AG\ - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 53 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2019. The put-call ratio across all filers is 26.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q2 2019$308,000
-31.4%
71,000
-10.8%
0.00%
Q3 2018$449,000
-42.3%
79,632
-55.0%
0.00%
Q2 2018$778,000
+718.9%
176,842
+1070.2%
0.00%
Q1 2018$95,000
-84.0%
15,112
-86.9%
0.00%
Q4 2017$593,000
-8.3%
115,217
+59.2%
0.00%
Q3 2017$647,000
+346.2%
72,350
+184.3%
0.00%
Q2 2017$145,000
+123.1%
25,450
+100.0%
0.00%
Q1 2017$65,000
+3.2%
12,724
+13.6%
0.00%
Q4 2016$63,000
-50.0%
11,200
-47.9%
0.00%
Q3 2016$126,00021,4770.00%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 815,789$3,541,0001.78%
MEITAV INVESTMENT HOUSE LTD 2,460,136$10,651,0000.71%
DAFNA Capital Management LLC 415,989$1,805,0000.68%
KNOTT DAVID M 259,377$1,126,0000.48%
SECTORAL ASSET MANAGEMENT INC 879,000$3,815,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 620,000$2,691,0000.37%
ESSEX INVESTMENT MANAGEMENT CO LLC 283,434$1,230,0000.17%
Harel Insurance Investments & Financial Services Ltd. 624,809$2,711,0000.14%
Avoro Capital Advisors LLC 820,000$3,559,0000.12%
MENTA CAPITAL LLC 52,792$229,0000.10%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders